A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials (2015)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/1745-6215-16-s2-p233
Publication URI: http://dx.doi.org/10.1186/1745-6215-16-s2-p233
Type: Journal Article/Review
Parent Publication: Trials
Issue: S2